蛋白酶系统在血友病性关节病中的潜在作用
血友病性关节病(HA)由反复关节出血引发滑膜炎症和软骨损伤。纤溶酶原激活系统尤其是uPA在关节出血后上调,uPA和纤溶酶可激活基质金属蛋白酶(MMPs),MMPs降解胶原和蛋白聚糖导致关节破坏。本文讨论纤溶酶原激活系统和MMPs可能加重HA关节损伤,为减少血友病共病提供新治疗靶点。
要点
- 关节出血后uPA强烈上调,催化纤溶酶生成,降解纤维蛋白及关节细胞外基质和软骨蛋白。
- uPA和纤溶酶可蛋白酶解生成活性MMPs,MMPs降解所有类型胶原和蛋白聚糖,破坏关节软骨。
- HA与类风湿关节炎和骨关节炎有重叠病理特征,纤溶酶原激活系统和MMPs可能加重HA关节损伤。
核心结论
- 纤溶酶原激活系统和MMPs可能加重血友病性关节病的关节损伤,为减少血友病共病提供新的潜在治疗靶点。
研究设计与样本
- 本文为综述,讨论纤溶酶原激活系统和MMPs在血友病性关节病中的作用。
主要发现
- 关节出血后uPA强烈上调,uPA催化生成纤溶酶,纤溶酶可降解纤维蛋白及关节细胞外基质和软骨蛋白。
- uPA和纤溶酶能蛋白酶解生成活性MMPs,MMPs家族包含20种以上蛋白酶,以无活性前酶形式分泌并在细胞外激活。
- MMPs参与降解构成细胞外基质的所有类型胶原和蛋白聚糖,细胞外基质为关节软骨提供结构支持。
- MMPs在类风湿关节炎关节破坏中作用明确,降解软骨和骨并间接促进血管生成,也参与骨关节炎病理。
- 血友病性关节病与类风湿关节炎和骨关节炎有若干重叠病理特征。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hemophilic arthropathy (HA) is characterized by joint damage following recurrent joint bleeds frequently observed in patients affected by the clotting disorder hemophilia. Joint bleeds or hemarthroses trigger inflammation in the synovial tissue, which promotes damage to the articular cartilage. The plasminogen activation system is integral to fibrinolysis, and the urokinase plasminogen activator, or uPA in particular, is strongly upregulated following hemarthroses. uPA is a serine protease that catalyzes the production of plasmin, a broad-spectrum protease that can degrade fibrin as well as proteins of the joint extracellular matrix and cartilage. Both uPA and plasmin are able to proteolytically generate active forms of matrix metalloproteinases (MMPs). The MMPs are a family of >20 proteases that are secreted as inactive proenzymes and are activated extracellularly. MMPs are involved in the degradation of all types of collagen and proteoglycans that constitute the extracellular matrix, which provides structural support to articular cartilage. The MMPs have an established role in joint destruction following rheumatoid arthritis (RA). They degrade cartilage and bone, indirectly promoting angiogenesis. MMPs are also implicated in the pathology of osteoarthritis (OA), characterized by degradation of the cartilage matrix that precipitates joint damage and deformity. HA shares a number of overlapping pathological characteristics with RA and OA. Here we discuss how the plasminogen activation system and MMPs might exacerbate joint damage in HA, lending insight into novel possible therapeutic targets to reduce the comorbidity of hemophilia.
引用
- Hauw WWS, Chia JSJ, Nandurkar HH, et al. The potential role of protease systems in hemophilic arthropathy. Blood Adv. 2022. PMID: 35580335. doi:10.1182/bloodadvances.2022007028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。